S-164 : Became Public Law


Advancing Education on Biosimilars Act of 2021

This bill requires the Food and Drug Administration (FDA) to advance education and awareness among health care providers about biological products as appropriate, including by developing or improving continuing education programs that address the prescribing of biological products and biosimilars. (A biosimilar is a biological product that is highly similar to an FDA-approved reference biological product and has no clinically meaningful differences from that reference product.)

The FDA may also maintain and operate a website to provide educational materials about biological products.

Action Timeline

Action DateTypeTextSource
2021-04-23PresidentBecame Public Law No: 117-8.Library of Congress
2021-04-23PresidentSigned by President.Library of Congress
2021-04-20FloorPresented to President.House floor actions
2021-04-14FloorMotion to reconsider laid on the table Agreed to without objection.House floor actions
2021-04-14VoteOn motion to suspend the rules and pass the bill Agreed to by the Yeas and Nays: (2/3 required): 412 - 8 (Roll no. 101). (text: CR H1754)House floor actions
2021-04-14FloorConsidered as unfinished business. (consideration: CR H1783-1784)House floor actions
2021-04-14FloorAt the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.House floor actions
2021-04-14FloorDEBATE - The House proceeded with forty minutes of debate on S. 164.House floor actions
2021-04-14FloorConsidered under suspension of the rules. (consideration: CR H1754-1755)House floor actions
2021-04-14FloorMr. Pallone moved to suspend the rules and pass the bill.House floor actions
2021-03-08FloorHeld at the desk.House floor actions
2021-03-08FloorReceived in the House.House floor actions
2021-03-08FloorMessage on Senate action sent to the House.Senate
2021-03-03FloorPassed Senate without amendment by Unanimous Consent. (text: CR S1021)Senate
2021-03-03DischargeSenate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent. (consideration: CR S1021)Senate
2021-02-02IntroReferralRead twice and referred to the Committee on Health, Education, Labor, and Pensions.Senate
2021-02-02IntroReferralIntroduced in SenateLibrary of Congress

Policy Area :

Health
Related Subjects
  • Drug safety, medical device, and laboratory regulation
  • Government information and archives
  • Health personnel
  • Licensing and registrations
  • Medical education
  • Prescription drugs
Related Geographic Entities
Related Organizations

Related Bills

See Related Bills